We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Marvell Technology
MRVL
$191B
| $1.24M | ﹤0.01% |
76,817
-2,084,807
| -96% | -$34.5M |
|
1427
National Healthcare
NHC
$3.39B
| $1.24M | ﹤0.01% |
15,770
-4,310
| -21% | -$337K |
|
1428
Alcoa
AA
$13.6B
| $1.24M | ﹤0.01% |
46,445
-1,835,498
| -98% | -$61.7M |
|
1429
Core Laboratories
CLB
$547M
| $1.24M | ﹤0.01% |
20,709
+18,727
| +945% | +$1.62M |
|
|
VGR
1430
DELISTED
Vector Group Ltd.
VGR
| $1.23M | ﹤0.01% |
187,637
-4,664
| -2% | -$39.4K |
|
|
AFI
1431
DELISTED
Armstrong Flooring, Inc.
AFI
| $1.23M | ﹤0.01% |
103,993
+63,406
| +156% | +$974K |
|
1432
TC Energy
TRP
$65.8B
| $1.23M | ﹤0.01% |
34,448
-26,007
| -43% | -$1.03M |
|
|
DCH
1433
Dauch Corp
DCH
$1.6B
| $1.23M | ﹤0.01% |
110,752
+1,438
| +1% | +$19.2K |
|
|
CSLT
1434
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.23M | ﹤0.01% |
565,256
+183,750
| +48% | +$456K |
|
1435
Turning Point Brands
TPB
$1.78B
| $1.23M | ﹤0.01% |
45,012
+14,954
| +50% | +$526K |
|
1436
EastGroup Properties
EGP
$10.9B
| $1.22M | ﹤0.01% |
13,317
+2,457
| +23% | +$237K |
|
|
SFBS
1437
ServisFirst Bancshares
SFBS
$4.82B
| $1.22M | ﹤0.01% |
38,284
-50,558
| -57% | -$1.82M |
|
1438
Nordson
NDSN
$17.2B
| $1.22M | ﹤0.01% |
10,214
+1,553
| +18% | +$191K |
|
|
CUTR
1439
DELISTED
Cutera, Inc.
CUTR
| $1.21M | ﹤0.01% |
71,094
-76,526
| -52% | -$1.56M |
|
1440
Acadia Pharmaceuticals
ACAD
$5.06B
| $1.21M | ﹤0.01% |
+74,727
| New | +$1.45M |
|
1441
Simply Good Foods
SMPL
$962M
| $1.21M | ﹤0.01% |
+63,770
| New | +$1.2M |
|
1442
Exponent
EXPO
$3.25B
| $1.2M | ﹤0.01% |
23,715
-897
| -4% | -$45K |
|
|
DF
1443
DELISTED
Dean Foods Company
DF
| $1.2M | ﹤0.01% |
314,944
-249,758
| -44% | -$1.51M |
|
|
VER
1444
DELISTED
VEREIT, Inc.
VER
| $1.2M | ﹤0.01% |
33,435
-10,299
| -24% | -$382K |
|
1445
New York Times
NYT
$10.4B
| $1.19M | ﹤0.01% |
53,566
-9,409
| -15% | -$238K |
|
1446
Macerich
MAC
$6.86B
| $1.19M | ﹤0.01% |
27,421
-5,828
| -18% | -$288K |
|
|
LHCG
1447
DELISTED
LHC Group LLC
LHCG
| $1.19M | ﹤0.01% |
12,637
+4,271
| +51% | +$408K |
|
1448
Seaboard Corp
SEB
$4B
| $1.19M | ﹤0.01% |
335
-181
| -35% | -$668K |
|
|
ITG
1449
DELISTED
Investment Technology Group Inc
ITG
| $1.18M | ﹤0.01% |
38,964
-77,939
| -67% | -$2.23M |
|
1450
CareTrust REIT
CTRE
$9.58B
| $1.18M | ﹤0.01% |
63,635
-1,777
| -3% | -$33.1K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.